Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
89
55
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice55
Redefining Fibrinolytic Insufficiency in Sepsis-Associated DIC50
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature42
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years41
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases39
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population37
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants35
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis35
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies34
Monitoring haemostatic function during extracorporeal membrane oxygenation with point-of-care viscoelastic assays: a narrative review33
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life33
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient32
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method32
Testing for Lupus Anticoagulants29
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only29
Platelet Function Testing: Update and Future Directions26
Thrombin Generation Assays in Clinical Hemostasis: From Mechanistic Insights to Clinical Applications26
Platelet Activation and Thrombosis in COVID-1925
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review25
Fifty Years of Fibrinogen Structure and Function25
Editorial Compilation—XIII24
External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific23
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future23
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review23
The History of Rare Bleeding Disorders21
Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies21
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey21
21
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review19
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives19
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice19
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III18
Bleeding in Patients with Renal Impairment: A Current Perspective18
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism18
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles18
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgM18
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase18
Toward 50 Years of Seminars in Thrombosis and Hemostasis18
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review17
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment17
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment17
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?16
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management16
16
15
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories15
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics14
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance14
Automation in Platelet Function Testing: Current Challenges and Future Directions14
Reply to the Comment: Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients14
Machine Learning Prediction of Stress-Induced D-dimer Reactivity in Male Physicians with and without Burnout14
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans14
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer14
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review14
2025 Eberhard F. Mammen Award Announcements–Part II: Young Investigator Awards14
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data14
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale14
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?14
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu14
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis13
13
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls13
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic13
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency13
Colchicine as a Modulator of Platelet Function: A Systematic Review13
Physical Activity in People with Hemophilia13
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives12
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities12
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?12
Venous Thromboembolism in Children: The Rivaroxaban Experience12
Editorial Compilation XIV12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications12
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials12
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection12
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review12
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis12
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)11
Thrombin Generation Assays: What are the Current Clinical Applications?11
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia11
Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization11
A Historical Perspective on the Reversal of Anticoagulants11
11
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art11
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis11
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions11
Acquired Hemostasis Disorders11
Platelet Physiology11
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature11
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles11
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome11
Editorial Compilation—Part XVIII11
Bleeding Scoring Systems in Neonates: A Systematic Review11
D-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program10
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?10
Precision Medicine in Rare Bleeding Disorders10
Do we Have the Gut to Beat Thrombosis?10
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review10
100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways—An Illustrative Case-Based Narrative Review9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing9
Von Willebrand Disease Type 2A: An Update9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism9
The Role of Platelets in Atherosclerosis: A Historical Review9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice9
9
NETosis in Acute Thrombotic Disorders9
Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series9
Non-factor Therapies for Hemophilia: Achievements and Perspectives9
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations9
Hemostasis Testing in the Emergency Department: A Narrative Review9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines9
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment9
8
Internal Quality Control in Hemostasis Assays8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction8
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?8
One Hundred Years of Congenital Fibrinogen Disorders8
Crucial Stepping Stones in Platelet History8
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality8
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?8
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care8
0.11687397956848